Page last updated: 2024-10-23

bepridil and Lung Diseases, Interstitial

bepridil has been researched along with Lung Diseases, Interstitial in 5 studies

Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.

Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.

Research Excerpts

ExcerptRelevanceReference
"Two patients presented with atrial fibrillation which was refractory to amiodarone but successfully treated with bepridil."7.73[Cardioversion of amiodarone-insensitive atrial fibrillation by bepridil in heart failure: two case reports]. ( Hadano, Y; Iwami, T; Kimura, M; Matsuzaki, M; Miyazaki, Y; Ogawa, H; Shimizu, A; Takaki, A; Wakeyama, T, 2006)
"Two patients presented with atrial fibrillation which was refractory to amiodarone but successfully treated with bepridil."3.73[Cardioversion of amiodarone-insensitive atrial fibrillation by bepridil in heart failure: two case reports]. ( Hadano, Y; Iwami, T; Kimura, M; Matsuzaki, M; Miyazaki, Y; Ogawa, H; Shimizu, A; Takaki, A; Wakeyama, T, 2006)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamasaki, K1
Yatera, K1
Noguchi, S1
Oda, K1
Akata, K1
Nishida, C1
Kawanami, T1
Kawanami, Y1
Ishimoto, H1
Ono, S1
Wakuta, Y1
Mukae, H1
Watanabe, M1
Takata, Y1
Fukasawa, S1
Sakota, K1
Abe, T1
Goseki, Y1
Setoguchi, Y1
Chikamori, T1
Yamashina, A1
Suzuki, T1
Hanaoka, M1
Yokoyama, T1
Koizumi, T1
Kubo, K1
Gaku, S1
Naoshi, K1
Teruhiko, A1
Kimura, M1
Ogawa, H1
Wakeyama, T1
Takaki, A1
Iwami, T1
Hadano, Y1
Miyazaki, Y1
Shimizu, A1
Matsuzaki, M1

Other Studies

5 other studies available for bepridil and Lung Diseases, Interstitial

ArticleYear
Incidence and outcomes of bepridil-induced interstitial pneumonia.
    Respiratory medicine, 2013, Volume: 107, Issue:12

    Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Bepridil; Calcium Channel Blockers; Female; Humans;

2013
Two patients with bepridil-induced interstitial pneumonia.
    Circulation journal : official journal of the Japanese Circulation Society, 2009, Volume: 73, Issue:7

    Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Bepridil; Diagnosis, Differential; Heart Failure;

2009
Gradual progression of interstitial pneumonia induced by bepridil.
    Internal medicine (Tokyo, Japan), 2009, Volume: 48, Issue:23

    Topics: Aged; Bepridil; Disease Progression; Humans; Lung Diseases, Interstitial; Male; Time Factors

2009
A case of bepridil induced interstitial pneumonitis.
    Heart (British Cardiac Society), 2003, Volume: 89, Issue:12

    Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Bepridil; Humans; Lung Diseases, Interstitial; Ma

2003
[Cardioversion of amiodarone-insensitive atrial fibrillation by bepridil in heart failure: two case reports].
    Journal of cardiology, 2006, Volume: 48, Issue:6

    Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bepridil; Cardiomy

2006